These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 7940835

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of HLA matching and T- and B-cell crossmatch on acute rejection and graft survival following liver transplantation.
    Chen M, Wade J, Levy GA, Greig PD.
    Transplant Proc; 1994 Oct; 26(5):2695-6. PubMed ID: 7940844
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cost-effective management of acute rejection in liver transplant recipients: a managed care perspective.
    Abouljoud MS, Brown KA, May E, Baliad P, Escobar FS, Mozes MF.
    Transplant Proc; 1997 Oct; 29(1-2):1557-9. PubMed ID: 9123423
    [No Abstract] [Full Text] [Related]

  • 6. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
    Sumrani N, Hong JH, DiBenedetto A, Clayton R, Miles AM, Markell MS, Distant DA, Fleishhacker J, Sommer BG.
    Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection.
    Wiesner RH, Porayko MK, Wahlstrom HE, Gores GJ, Kamath PS, Hay JE, Krom RA.
    Transplant Proc; 1993 Apr; 25(2):1791-3. PubMed ID: 7682352
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cyclosporine Neoral in liver transplant recipients.
    Levy G, Rochon J, Freeman D, Wong PY, Banks L, Roach C, Engel K, Grant D.
    Transplant Proc; 1994 Oct; 26(5):2949-52. PubMed ID: 7940930
    [No Abstract] [Full Text] [Related]

  • 11. Relative clinical impact of cyclosporine vs steroid induction therapy on renal function and allograft rejection in heart transplant recipients.
    Hanrahan JS, Ibrahim H, Tolman D, Kirchberg D, Salter D, Guerraty A, Mohanty PK.
    Transplant Proc; 1996 Aug; 28(4):2107-8. PubMed ID: 8769168
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Low incidence of chronic rejection in patients experiencing histological acute rejection without simultaneous impairment in liver function tests.
    Farges O, Nocci Kalil A, Sebagh M, Reynes M, Bismuth H.
    Transplant Proc; 1995 Feb; 27(1):1142-3. PubMed ID: 7878827
    [No Abstract] [Full Text] [Related]

  • 16. Induction immunosuppressive therapy is associated with a low rejection rate after liver transplantation.
    McVicar JP, Kowdley KV, Emond MJ, Barr D, Marsh CL, Carithers RL, Perkins JD.
    Clin Transplant; 1997 Aug; 11(4):328-33. PubMed ID: 9267724
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease.
    Woodle ES, Perdrizet GA, So S, Jendrisak MD, White HM, Marsh JW.
    Transplant Proc; 1993 Apr; 25(2):1992-3. PubMed ID: 7682360
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. OKT3 as prophylaxis immunosuppression in pediatric liver transplant recipients.
    Sommerauer JF, Atkison P, Howard J, Grant D, Wall W.
    Transplant Proc; 1994 Feb; 26(1):154-6. PubMed ID: 8108917
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.